Tissue Doppler echocardiography and biventricular pacing in heart failure: Patient selection, procedural guidance, follow-up, quantification of success

Heart failure is among the most common chronic diseases in modern civilizations. The dilatation of the left ventricle frequently induces intracardiac conduction delays resulting in asynchronous left ventricular motion. This manifests as left bundle branch block in the surface ECG. Both QRS width and intraventricular asynchrony are predictors of hospitalization and severe cardiac events in patients with heart failure [1‐3].

The mechanisms of myocardial asynchrony include a delayed left ventricular regional contraction and relaxation. The right ventricle contracts during left ventricular end-diastole, leading to a "bulging" of the septum into the left ventricle. The intra(left)ventricular delay of the systolic velocity induces the "delayed longitudinal contraction (DLC)". Furthermore, the delay of the contraction of the papillary muscles aggravates mitral regurgitation. This, in summary, leads to an increased oxygen demand of the myocardium [4].

Resynchronization of the intraventricular conduction can be achieved by introducing an additional lead through the coronary venous sinus to stimulate the left ventricle (biventricular pacing, BVP). The combination of BVP and a cardioverter-defibrillator (ICD) combines the clinical improvement by BVP and reduction in mortality [5]. Recent studies have shown an acute and sustained hemodynamic improvement, reversal of LV-remodeling, an increased quality of life, a reduction of symptoms of heart failure, and improvement of exercise tolerance after biventricular pacing. Markers of reverse remodeling were reduction of left ventricular volumes, increase in LVEF without an increase in oxygen consumption, reduction of mitral regurgitation [6‐10]. However, a significant reduction of mortality after BVP alone could not be demonstrated.

In the current guidelines, LBBB in the surface ECG and a reduced LVEF are the main indications for BVP [11]. However, about one third of patients in the large multicenter BVP studies did not improve – despite BVP [6, 7, 12]. There is increasing evidence, that there is only a weak correlation of electrical (QRS width) and mechanical asynchrony and the benefit of BVP. It seems that not all heart failure patients with LBBB have mechanical asynchrony [12, 13].

Furthermore, asynchrony is common even in heart failure patients with narrow QRS complexes compared with healthy controls. A prospective study assessed left ventricular systolic and diastolic asynchrony in 67 patients with heart failure (LVEF < 50%) with normal QRS width and 45 patients with CHF and wide QRS complexes (>120 ms). 88 healthy control patients were included. Systolic (diastolic) asynchrony occurs in 51% (46%) of the heart failure patients with narrow QRS complexes and in 73% (69%) in the patients with wide QRS complexes. Systolic asynchrony was defined as the max difference in time-to-peak myocardial contraction of 12 myocardial segments. Diastolic asynchrony was defined as maximum difference of time-to-peak early diastolic relaxation. In summary, the authors state that asynchrony is common in patients with heart failure even without a wide QRS complex [14]. This is confirmed in a study with 158 heart failure patients (LVEF < 35%), that were divided in three subgroups: Group 1 with no (QRS < 120 ms), group 2 with mild (120–150 ms) and group 3 with severe LBBB (>150 ms). Interventricular asynchrony was defined by TDI as IVMD >40 ms and the intraventricular delay as maximum pre-ejection period of >50 ms in one or more myocardial segments. Asynchrony was seen in all three subgroups, however, there was no correlation between interventricular and intraventricular asynchrony [15].

A recent study demonstrated that successful BVP can be achieved in patients with a normal QRS duration and asynchrony [16, 17].

These controversial data indicate the need for a more careful patient selection for BVP. Newer echocardiographic techniques, such as Tissue Doppler Imaging and Tissue Synchronization Imaging could potentially improve patient selection and guidance of implantation and programming of the devices for BVP. The risks of pacemaker implantation and expenses in non-responders to BVP could be avoided. Furthermore, the cost-effectiveness of BVP would be augmented.

Regarding the nomenclature, the term "asynchrony" is used synonymously to "dyssynchrony" in this article. There is a variety of methods to determine asynchrony. In table 1, the different approaches to asynchrony are listed concisely. The QRS width (LBBB > 120, 130, 150 ms) is the simplest method, but the sensitivity to predict benefit from BVP is rather low [18, 19]. Magnetic resonance imaging can also detect areas of asynchrony but this technique can not be repeated for follow-up after device implantation.

Echocardiographic tools include 2D, Doppler and Tissue Doppler methods. Up to date, there is no consensus on the definition of echocardiographically measured myocardial asynchrony. The determination of asynchrony by M-mode echocardiography is limited to septal and inferior segments in parasternal long-axis and is not performed routinely in current studies [20, 21]. Earlier echocardiographic approaches to asynchrony included the delayed long axis shortening that was found to suppress early diastolic transmitral flow and subsequently leading to decreased leftventricular function [22].

Tissue Doppler imaging (TDI) measures regional wall motion velocities. TDI can accurately quantify regional left ventricular function [23]. Pulsed wave TDI does not allow simultaneous comparison of regional timing in different segments within one cardiac cycle. Color-coded TDI reduces beat-to-beat variability and examination time. Color coded TDI has a very high time resolution of 10 ms.

TDI technology includes tissue tracking and strain rate imaging. Tissue tracking allows the measurement and visualization of longitudinal motion in each myocardial segment during the different phases of the heart cycle.

Strain measures compression and distension of myocardial segments ("deformation imaging") and strain rate imaging expresses strain changes per time interval. Post-systolic movement diagnosed with velocity or tissue tracking can be differentiated into passive or active motion (=contraction, then defined as PSS). But in ischemic cardiomyopathy PSS was not an useful criterion for response to BVP because this phenomenon is not only a sign of asynchrony but also a marker for ischemia and/or viability of severe hypo/akinetic segments [24].

Tissue synchronization imaging (TSI) is a newer technique that utilizes color-coded time-to-peak tissue Doppler velocities and visualizes segments of dyssynchrony in real-time by superimposing these temporal motion data on 2D echo images. TSI analysis is possible in all myocardial regions except the apex. The color-coding is green (normal time-to-peak velocity: 20–150 ms), yellow (150–300 ms) and red (300–500 ms) [25]. Online 3D echocardiography and automated border detection (ABD) might be future diagnostic tools to diagnose asynchrony but need evaluation in larger studies [26].

Myocardial asynchrony includes inter- and intraventricular asynchrony. Interventricular asynchrony can be assessed by comparing pw-Doppler signals in the right and left ventricular outflow tracts. A delay of >60 ms is considered to demonstrate interventricular asynchrony. These measurements in the outflow tracts cannot be performed simultaneously and, therefore, there is a high inter-measurement variability and dependence on cardiac workload. In addition, interventricular asynchrony can measured as the difference of the electromechanical delays in the basal LV segments and the lateral RV segments [35].

Intra(left)ventricular asynchrony is considered to be the most important aspect of the electromechanical delay (EMD). It can be measured by a variety of methods. EMD is defined as the delay between the onset of the QRS complex on the surface ECG and the onset of the systolic TDI wave in corresponding myocardial segments. Recently, the systolic synchronicity index has been introduced [27]. It is defined as the standard deviation (SD) of the EMD in 12 LV segments (6 basal, 6 mid-segmental model).

Intraventricular asynchrony can also be demonstrated by tissue tracking with diastolic color-coded areas called DLC. This is the amount of post-systolic contraction after the closure of the aortic valve (i.e. post systolic shortening = PSS) which was confirmed by strain and strain rate in this study [28].

Intra-left ventricular asynchrony is not only of diagnostic value for selecting patients for BVP, but has prognostic value as well. Bader et al. [3] examined inter- and intraventricular asynchrony as an independent predictor of heart failure worsening: 104 patients with chronic stable heart failure without previous myocardial infarction (LVEF < 45%) were included, follow-up echocardiography was performed after one year. Study endpoint of heart failure worsening was hospitalization for cardiac decompensation. Intra-left ventricular asynchrony is an independent predictor of severe cardiac events. Only a weak correlation of intra/inter-ventricular EMD and QRS width could be demonstrated.

In figures 1, 2, 3, 4, 5, 6, 7, 8, 9, the different approaches to assess asynchrony as well as echocardiographic examples of successful biventricular pacing are illustrated.

Only limited data are published concerning prospective echocardiography based patient selection for BVP. Bordachar et al. [29] performed a prospective study to identify TDI parameters that would predict the benefit of upgrading right ventricular pacing to BVP. 26 patients with normal LVEF and RVP and 16 patients with CHF and RVP were included. EMD was defined as the interval between the stimulation spike and the onset of the S wave. An intra-ventricular EMD of >50 ms identifies patients with significant asynchrony. No correlation between asynchrony and QRS width was seen in the heart failure patients. ECG criteria would have misclassified 44% of the patients for mechanical ventricular asynchrony. This study has defined relevant asynchrony but did not assess the hemodynamic or electromechanical effects after upgrade to BVP nor effects on morbidity and mortality.

Several studies were performed to retrospectively correlate markers of asynchrony to benefit from BVP.

Lafitte [30] has included 15 patients with idiopathic DCM and a QRS of more than 140 ms (NYHA III-IV, LVEF < 35%, LVEDD > 60 mm) for BVP. Measurement of EMD was performed at baseline and after one month. This study has found that BVP reduces EMD in the lateral left ventricular wall.

In another study [25], 49 patients with heart failure (QRS > 130 ms, LVEF < 35%, NYHA II-IV) were included. Retrospectively, intra- and interventricular and the combined index of asynchrony (=the sum of left and right ventricular asynchrony) were assessed at baseline and after 6 months of BVP by pulsed wave TDI. The cut-off-values for LV-asynchrony was 60 ms (56 ms for RV-LV-asynchrony and 102 ms for the "sum-asynchrony"). By definition, patients with a relative increase in LVEF of more than 25% were classified as responders to BVP. Receiver-operating characteristics (ROC) analysis showed that the degree of echocardiographic asynchrony is superior to QRS width in predicting hemodynamic and clinical improvement after BVP compared to QRS duration or conventional echo data. In 82% of the patients, the benefit of BVP could have been predicted echocardiographically.

The role of TDI and 3D echo on the long term (1 year) outcome after BVP was evaluated in 25 patients [19]. The extent of DLC in the basal segments at baseline predicted the long-term efficacy of BVP. The LV base DLC was reduced from 18,7% to 8.1% after BVP. In concordance with other studies, the QRS duration failed to predict BVP efficacy [28].

The myocardial segments with the best resynchronization after BVP were studied in 18 patients with an LVEF <35% and a QRS width of >120 ms (NYHA III-IV). Color tissue Doppler velocity imaging was performed from the apical four chamber view at baseline and one month of follow-up after BVP [31]. Peak velocities and regional time differences in basal and mid septal segments were compared to the corresponding lateral segments. At baseline, a regional asynchrony of 42 ms in the basal sites (only 14 ms in the mid left ventricular site) was measured. After one month of BVP, a reduction of asynchrony was seen in only the basal segments but not in the mid segments. In conclusion, it was suggested that hemodynamic improvement is mainly in basal sites.

Reverse remodeling and improved synchrony after 3 months of BVP was evaluated in 25 patients [32]. Asynchrony was assessed as time-to-peak regional sustained systolic contraction (=Ts). After three months, a homogenous left ventricular delay of Ts, improved interventricular synchrony and a reduced isovolumic contraction time and increased diastolic filling time were documented. These beneficial effects were reversible after withholding BVP. In a univariate analysis, systolic dyssynchrony was the only independent predictor of reverse remodeling after three months [33].

One recent study has compared the value of TDI and SRI and post-systolic shortening in the prediction of reverse remodeling after BVP: The previously introduced asynchrony index (=Ts-SD) based on Tissue Doppler velocity data has the highest predictive value of reverse remodeling after BVP. PSS has predictive power only in non-ischemic heart failure. In ischemic heart failure, PSS seems not to be a marker for reverse remodeling but rather reflects viability and is therefore not altered by BVP. SRI imaging techniques did not predict reverse remodeling after three months of BVP [33]. This is in contrast to previously published data [34].

Kanzaki has introduced the synchrony index, which is defined as the correlation coefficient of linear regression of velocity of septal and lateral mitral annular region. This index showed an increase after 6 months of BVP paralleled by increased LV contractility [35].

One study [36] has retrospectively evaluated the use of TSI to predict the acute response to BVP in 29 patients. The acute benefit to BVP was defined as a >15% increase in echocardiographically measured stroke volume 48 h after device implantation. A difference of >65 ms in time-to-peak velocity in anteroseptal and posterior segments in the apical long axis view was associated with acute improvement after BVP. However, the ability of TSI to predict long-term improvement after BVP needs further evaluation.

TDI could play a role in identifying patients during catheterization procedures that will profit from BVP. Catheterization studies have shown that the beneficial effects of BVP begin almost immediately [37, 38]. But systematic evaluation with TDI-technique is currently ongoing.

Furthermore, TDI can assist in finding the optimal pacing site for the coronary sinus lead. In 31 patients, it was documented that LV-stimulation on the site of longest EMD had the best benefit of BVP. The regional asynchrony was assessed by pw-TDI and the pacing site was determined fluoroscopically [39]. Lateral and postero-lateral LV lead positions were retrospectively found to improve left ventricular hemodynamics [40].

About one third of patients with heart failure have atrial fibrillation. The large trials, however, have only included patients in sinus rhythm. Only small studies with controversial results were performed in patients with atrial fibrillation and LBBB. Leclercq has performed one study in 59 NYHA III patients with chronic atrial fibrillation, a slow ventricular rate and the need for permanent pacing (VVI-paced QRS width of >200 ms). Due to a high drop out rate, the results did not show a significant increase in 6-min-walk distance after BVP [44]. Larger trials are needed to evaluate BVP for patients with atrial fibrillation.

We have performed a double-blind cross-over study in our clinic to assess the use of new echocardiographic techniques in BVP. Patients (n = 40) with a QRS >140 ms and a LVEF <35% received an InSyncICD 7272 (Medtronic, Minneapolis, Minnesota, USA). Preliminary results (n = 8) after two years demonstrate a reduction of the septal-posterior delay from 264 (±23) msec to 234 (±34) msec (p < 0,05) and a stabilization of clinical (NYHA class improvement) and hemodynamic status (EF and LV volumes). The study is ongoing.

The following video loops underline the utility of TSI and Tissue Tracking to document improvement of synchronicity after BVP. In additional file 1 shows asynchrony before BVP implantation in apical four chamber view by TSI. In additional file 2 the effect of BVP is shown. in additional file 4 shows the acute changes of BVP as documented in this video loop by Tissue Tracking from apical four chamber view compared to baseline (additional file 3). The long-term effect of BVP after six months is illustrated in additional file 5 (baseline) and additional file 6 (after 6 months).

Many controlled and uncontrolled studies have demonstrated that new echocardiographic tools to determine myocardial asynchrony in heart failure patients will help to select patients for BVP help guidance of implantation and optimize device programming. To date, all studies employing tissue Doppler date were performed retrospectively. No prospective studies that have selected patients for BVP according to echocardiographic evaluation of asynchrony were performed yet. The ongoing CARE-HF study incorporates echocardiographic criteria of asynchrony in a subset of patients with a QRS of 120–150 ms [45]; results are not expected until 2005. The criteria of asynchrony in this study are (1) aortic pre-ejection delay >140 ms, (2) the mechanical interventricular (pw aortic valve vs. pulmonary valve) delay >40 ms and (3) the demonstration of left ventricular post-systolic contraction by M-mode and/or Tissue Doppler.

Unresolved issues include different opinions regarding the various elements of asynchrony and their contribution to the pathophysiology and progression of heart failure. There is a lack of consensus about the best asynchrony marker for patient selection. There is evidence that ischemic and dilated cardiomyopathy might have different selection parameters for BVP. The practical consequences for patient selection and/or implantation site of the lead are currently under investigation. There are only limited echocardiographic data regarding the programming of the optimal interventricular (V-V) delay. There are no data concerning the long-term effect (i.e. years) of BVP on hemodynamics, amelioration of mitral regurgitation, reverse remodeling and mortality. Another area of uncertainty is the selection of patients for BVP without electrical (QRS < 120 ms) but with mechanical asynchrony.

F Knebel and AC Borges have performed the literature review and have prepared the manuscript. RK Reibis, have performed echocardiographic examinations for this article. HJ Bondke and J Witte and G Baumann have selected patients for BVP. HJ Bondke and J Witte have implanted the biventricular pacing devices. All authors have read and approved the final version of the manuscript.